Epidermal growth factor receptor (EGFR) induced activation of the transcription factor NF-κB may be involved in the malignant behavior of EGFR overexpressing tumor cells, such as in lung cancer and gastric carcinoma [9, 10]. This evidence concerns the gene NFKB1 and neoplasm.